In­tas Phar­ma­ceu­ti­cal­s' In­di­an fa­cil­i­ty hit with FDA warn­ing let­ter, placed on im­port alert

In­tas Phar­ma­ceu­ti­cals has been is­sued an­oth­er warn­ing let­ter af­ter FDA in­spec­tors un­cov­ered ma­nip­u­lat­ed records and con­t­a­m­i­na­tion is­sues at its fa­cil­i­ty in Gu­jarat, In­dia fol­low­ing a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER